Evidence map›Paper›PMID 31966673›Full record

ArticleInternational journal of clinical and experimental pathology2017

High-grade serous ovarian and fallopian tube carcinomas with similar clinicopathological characteristics might originate from serous tubal intraepithelial carcinoma in Chinese women.

Jingmei Wang, Hongyan Wu, Yan Zhang, Yifen Zhang, Xinxiu Li, Qingya Zhao, Fanqing Meng, Qin Huang, Yaping Wang

Open access · greenAbstract read
In one paragraph

Article in International journal of clinical and experimental pathology, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
0.3field-weighted citation impact, top 28% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed, 3 citations in OpenAlex.

  1. Estimating the Opportunity for Early Detection of Ovarian Cancer Using Individual-Patient Data from a Large Randomized Controlled Trial.Cancer epidemiology, biomarkers & prevention : a publication of the American Association for Cancer Research, cosponsored by the American Society of Preventive Oncology · 2025
    Trial
  2. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors at 1 institution in 1 country.

Jingmei WangDepartment of Pathology, Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing, Jiangsu Province, China.
Hongyan WuDepartment of Pathology, Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing, Jiangsu Province, China.
Yan ZhangDepartment of Obstetrics and Gynecology, Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing, Jiangsu Province, China.
Yifen ZhangDepartment of Pathology, Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing, Jiangsu Province, China.
Xinxiu LiJiangsu Key Laboratory of Molecular Medicine, Department of Medical Genetics, Nanjing University Medical School Nanjing, Jiangsu Province, China.
Qingya ZhaoJiangsu Key Laboratory of Molecular Medicine, Department of Medical Genetics, Nanjing University Medical School Nanjing, Jiangsu Province, China.
Fanqing MengDepartment of Pathology, Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing, Jiangsu Province, China.
Qin HuangDepartment of Pathology, Affiliated Drum Tower Hospital of Nanjing University Medical School Nanjing, Jiangsu Province, China.
Yaping WangJiangsu Key Laboratory of Molecular Medicine, Department of Medical Genetics, Nanjing University Medical School Nanjing, Jiangsu Province, China.
Nanjing Drum Tower Hospital · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

aimsThis study aimed to compare the clinicopathological features, incidence, and prognosis between type II ovarian carcinoma (OC) and fallopian tube carcinoma (FTC) in Chinese women and to analyze the origin of high-grade serous carcinoma (HGSC).

methodsThree hundreds and seventy-four OC cases and 45 FTC cases were retrospectively studied with histomorphology, tissue microarray, and immunohistochemistry.

resultsOur data showed that the characteristics of OC and FTC in Chinese women were younger at diagnosis with worse prognosis. There was no significant difference between type II OC and FTC in the clinicopathological information and survival. Serous tubal intraepithelial carcinoma (STIC) were found in 41.7% (43/103) of ovarian high-grade serous carcinoma (HGSC) and 52.4% (22/42) cases of tubal HGSC, and 26 patients were found with only fallopian tube (FT) mucosal invasive carcinoma. Seventy-eight of 87 cases of ovarian HGSC with tubal lesions (STIC and/or FT mucosal invasive carcinoma) was in advanced stage. There was no significant difference between newly assigned FTC (ovarian HGSC with tubal lesions and FTC) and type II OC without tubal lesions in many clinicopathological parameters, expression of immunohistochemical indicators and survival, but type I OC was quite much different from the former two.

conclusionsOur data suggested that OC of type II and FTC might be originated from the same organ, and strongly supported the dualistic model of epithelial ovarian cancer. Moreover, this study provided a further clinical basis for the prophylactic salpingectomy to reduce the risk of OC.

Indexed as

Chinese womenfallopian tube cancerhigh-grade serous carcinomaOvarian cancerserous tubal intraepithelial carcinoma

Identifiers

PMID31966673
PMCPMC6965390
OpenAlexW3027982509

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.